Pigmentation and Scaring Management after Hypodermoclysis, a Case Report

Kamal Alhallak,Dima Omran,Salem Tomi,Adel Abdulhafid

doi:10.3390/cosmetics9010010

Abstract

Hypodermoclysis is the continuous subcutaneous infusion of a parenteral solution into dermal tissue, which is typically associated with skin lesions and cosmetic issues in the majority of patients. Scarring and pigmentation are two of the potential skin lesions after hypodermoclysis. The way skin diseases and cosmetic issues are treated has altered dramatically as a result of laser technology. This is the first article to our knowledge that describes the treatment of pigmentation and scarring produced by Hypodermoclysis cutaneous damage by using laser treatment. It was vital to select the appropriate endpoint, technology, and configuration parameters. The lesion was completely resolved after five months of treatment with four laser sessions. The first session used a fractional Er-Yag laser to perform cold ablation. The remaining sessions used 1064 and 585 nm Nd-Yag Q-switch lasers to operate in the nanosecond region. To minimize the danger of post-inflammatory hyperpigmentation (PIH), the treated region was prepped between laser treatments with 4% hydroquinone (HQ) cream. Our protocol may reduce scars and pigmentation while minimizing adverse effects and downtime.

Highlights

Hypodermoclysis (HDC) is the continuous subcutaneous infusion of a parenteral solution into the dermal tissue
Depending on the time frame and type of infused fluid, HDC is associated with varying degrees of tissue disruption, primarily cutaneous injury
Reports of cosmetic skin lesions and complications after HDC and subcutaneous infusion have primarily focused on type I diabetes patients who use insulin pumps [3,4,5]

Summary

Introduction

Hypodermoclysis (HDC) is the continuous subcutaneous infusion of a parenteral solution into the dermal tissue. Reports of cosmetic skin lesions and complications after HDC and subcutaneous infusion have primarily focused on type I diabetes patients who use insulin pumps [3,4,5]. These reports were purely observational, with no discussion of treatment options [6]. Our review of the literature revealed that no reports on laser treatment for pigmentation or scarring caused by hypodermoclysis had been published. The laser technologies available for the treatment of skin lesions have undergone a revolution in the last decade [10]. Experts usually design a protocol that includes various laser technologies and settings that target different chromophores [12,13]

Case Report conditions of the Creative Commons

Lesion Assessment

Stage One

Discussion

Conclusions